Your browser doesn't support javascript.
loading
Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.
Eda, Takeyoshi; Okada, Masayasu; Ogura, Ryosuke; Tsukamoto, Yoshihiro; Kanemaru, Yu; Watanabe, Jun; On, Jotaro; Aoki, Hiroshi; Oishi, Makoto; Takei, Nobuyuki; Fujii, Yukihiko; Natsumeda, Manabu.
Afiliación
  • Eda T; Division of Pharmacy, Medical and Dental Hospital, Niigata University, Niigata 951-8520, Japan.
  • Okada M; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Ogura R; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Tsukamoto Y; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Kanemaru Y; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Watanabe J; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • On J; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Aoki H; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Oishi M; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Takei N; Department of Brain Tumor Biology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Fujii Y; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
  • Natsumeda M; Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Cancers (Basel) ; 14(3)2022 Feb 02.
Article en En | MEDLINE | ID: mdl-35159037

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Japón